AzTrials
AzTrials

Glycemic ControlNCT01812967

Mechanism of Action of Milk and Its Components on Glycemic Control in Healthy Young Men

A study testing Milk Fat, Milk Protein and Lactose in people with Glycemic Control and Gastrointestinal Hormone Response, run by University of Toronto at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators hypothesize that the physiological effects of milk on satiety and glycemic control are mediated by the interaction between its macronutrient components by both insulin-dependent and independent mechanisms. Read more about this study

Who is it for?
Ages 20 to 30 years, men onlyHealthy volunteers can take part
What is being tested?
Milk Fat, Milk Protein and Lactose
How many people
12 participants
Where
1 siteCanada
Study dates
Start not givento Sep 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy young men
  • 20-30 years of age
  • BMI: 20-24.9 kg/m2

Who cannot join

  • Smoking
  • Dieting
  • Skipping breakfast
  • Lactose intolerance or allergies to milk
  • Taking medications that may affect glucose metabolism or appetite
  • Diabetes (fasting blood glucose ≥ 7.0 mmol/L) or other metabolic diseases

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Toronto

    Toronto, Ontario, M5S 3E2

Other trials in Canada

About this study

The investigators hypothesize that the physiological effects of milk on satiety and glycemic control are mediated by the interaction between its macronutrient components by both insulin-dependent and independent mechanisms.

Being tested
Milk Fat, Milk Protein, Lactose, Whole milk (3.25% M.F.(, Simulated Milk Beverage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Milk FatDietary supplement

  • Milk ProteinDietary supplement

  • LactoseDietary supplement

  • Whole milk (3.25% M.F.(Other

    Commercially available milk from the grocery store

  • Simulated Milk BeverageDietary supplement

    Added lactose + fat + protein together to form a mixture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glucose

    Measured: 0-180 min

Secondary outcomes (1)
  1. Insulin

    Measured: 0-180 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2013 (estimated)
  2. Primary completionSep 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01812967
Sponsor's protocol ID
Milk Components Study
Status last verified
Mar 2013
First submitted
13 Mar 2013
Last updated
18 Mar 2013
Results posted
No

Publications

  • Panahi S, El Khoury D, Kubant R, Akhavan T, Luhovyy BL, Goff HD, Anderson GH. Mechanism of action of whole milk and its components on glycemic control in healthy young men. J Nutr Biochem. 2014 Nov;25(11):1124-1131. doi: 10.1016/j.jnutbio.2014.07.002. Epub 2014 Jul 31.

    PubMed 25167977

Questions about this trial

What is this clinical trial studying?

A study testing Milk Fat, Milk Protein and Lactose in people with Glycemic Control and Gastrointestinal Hormone Response, run by University of Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glucose (time frame: 0-180 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01812967, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in